Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Califf

Showing results (321-330 of 770) with videos related to

Pageof 77
Sort By:
The New England Journal of Medicine|October 25, 2002
A national survey of provisions in clinical-trial agreements between medical schools and industry sponsorsKevin A Schulman, Damon M Seils, Justin W Timbie, et al.
Journal of Women'S Health (2002)|January 27, 2005
Postmenopausal hormone use in women with acute coronary syndromesElizabeth Parsons, L Kristin Newby, Manjushri V Bhapkar, et al.
Journal of Cardiac Failure|December 16, 2004
Risk stratification after hospitalization for decompensated heart failureG Michael Felker, Jeffrey D Leimberger, Robert M Califf, et al.
Contemporary Clinical Trials|June 23, 2019
Impact of baseline covariate imbalance on bias in treatment effect estimation in cluster randomized trials: Race as an exampleSiyun Yang, Monique Anderson Starks, Adrian F Hernandez, et al.
Kidney International|July 4, 2008
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomesLynda A Szczech, Huiman X Barnhart, Jula K Inrig, et al.
American Heart Journal|November 26, 2013
Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular diseaseJennifer B Green, M Angelyn Bethel, Sanjoy K Paul, et al.
Journal of the American College of Cardiology|January 28, 2017
Improving Medication Adherence in Cardiometabolic Disease: Practical and Regulatory ImplicationsKeith C Ferdinand, Fortunato Fred Senatore, Helene Clayton-Jeter, et al.
American Heart Journal|April 29, 2008
Antithrombotic drug development for atrial fibrillation: proceedings, Washington, DC, July 25-27, 2005Kevin Jackson, Bernard J Gersh, Norman Stockbridge, et al.
American Heart Journal|April 29, 2008
Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predictDerek P Chew, Kenneth W Mahaffey, Harvey D White, et al.
The American Journal of Cardiology|September 16, 2003
Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventionsDavid F Kong, Vic Hasselblad, Robert A Harrington, et al.
Pageof 77

Showing results (321-330 of 770) with videos related to

Sort By:
Pageof 77
The New England Journal of Medicine|October 25, 2002
A national survey of provisions in clinical-trial agreements between medical schools and industry sponsorsKevin A Schulman, Damon M Seils, Justin W Timbie, et al.
Journal of Women'S Health (2002)|January 27, 2005
Postmenopausal hormone use in women with acute coronary syndromesElizabeth Parsons, L Kristin Newby, Manjushri V Bhapkar, et al.
Journal of Cardiac Failure|December 16, 2004
Risk stratification after hospitalization for decompensated heart failureG Michael Felker, Jeffrey D Leimberger, Robert M Califf, et al.
Contemporary Clinical Trials|June 23, 2019
Impact of baseline covariate imbalance on bias in treatment effect estimation in cluster randomized trials: Race as an exampleSiyun Yang, Monique Anderson Starks, Adrian F Hernandez, et al.
Kidney International|July 4, 2008
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomesLynda A Szczech, Huiman X Barnhart, Jula K Inrig, et al.
American Heart Journal|November 26, 2013
Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular diseaseJennifer B Green, M Angelyn Bethel, Sanjoy K Paul, et al.
Journal of the American College of Cardiology|January 28, 2017
Improving Medication Adherence in Cardiometabolic Disease: Practical and Regulatory ImplicationsKeith C Ferdinand, Fortunato Fred Senatore, Helene Clayton-Jeter, et al.
American Heart Journal|April 29, 2008
Antithrombotic drug development for atrial fibrillation: proceedings, Washington, DC, July 25-27, 2005Kevin Jackson, Bernard J Gersh, Norman Stockbridge, et al.
American Heart Journal|April 29, 2008
Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predictDerek P Chew, Kenneth W Mahaffey, Harvey D White, et al.
The American Journal of Cardiology|September 16, 2003
Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventionsDavid F Kong, Vic Hasselblad, Robert A Harrington, et al.
Pageof 77